- Home
- HTOO vs MYNZ Comparison
HTOO vs MYNZ Comparison
Compare HTOO & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTOO
- MYNZ
- Stock Information
- Founded
- HTOO 2020
- MYNZ 2021
- Country
- HTOO Ireland
- MYNZ Germany
- Employees
- HTOO N/A
- MYNZ N/A
- Industry
- HTOO Natural Gas Distribution
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- HTOO Utilities
- MYNZ Health Care
- Exchange
- HTOO Nasdaq
- MYNZ Nasdaq
- Market Cap
- HTOO 12.3M
- MYNZ 11.2M
- IPO Year
- HTOO N/A
- MYNZ 2021
- Fundamental
- Price
- HTOO $0.49
- MYNZ $3.78
- Analyst Decision
- HTOO Strong Buy
- MYNZ Hold
- Analyst Count
- HTOO 1
- MYNZ 2
- Target Price
- HTOO $3.50
- MYNZ N/A
- AVG Volume (30 Days)
- HTOO 16.4M
- MYNZ 128.8K
- Earning Date
- HTOO 12-24-2024
- MYNZ 10-21-2024
- Dividend Yield
- HTOO N/A
- MYNZ N/A
- EPS Growth
- HTOO N/A
- MYNZ N/A
- EPS
- HTOO N/A
- MYNZ N/A
- Revenue
- HTOO $4,580,524.00
- MYNZ $917,203.00
- Revenue This Year
- HTOO $329.95
- MYNZ $36.69
- Revenue Next Year
- HTOO $344.33
- MYNZ $91.67
- P/E Ratio
- HTOO N/A
- MYNZ N/A
- Revenue Growth
- HTOO N/A
- MYNZ 16.23
- 52 Week Low
- HTOO $0.28
- MYNZ $0.18
- 52 Week High
- HTOO $4.65
- MYNZ $7.95
- Technical
- Relative Strength Index (RSI)
- HTOO 51.31
- MYNZ 53.35
- Support Level
- HTOO $0.42
- MYNZ $4.30
- Resistance Level
- HTOO $0.59
- MYNZ $7.95
- Average True Range (ATR)
- HTOO 0.11
- MYNZ 0.91
- MACD
- HTOO 0.01
- MYNZ -0.15
- Stochastic Oscillator
- HTOO 42.65
- MYNZ 46.33
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.